Introduction
Since the pioneering work of Barker et al., 1 magnetic stimulation of the nervous system has become increasingly efficient due to the development of powerful and rapid stimulators. Repetitive transcranial magnetic stimulation (rTMS) applied at appropriate stimulation frequency and intensity can transiently block or inhibit focal brain activity as does conventional electrical stimulation. [2] [3] [4] [5] [6] [7] Magnetic coil stimulation can also be applied to the peripheral nervous system with the advantage over electrical stimulation of producing little discomfort and requiring no invasive procedures to reach relatively deep structures. 8, 9 It is well established that the interference effect of electrical stimulation on the peripheral nervous system can reduce localized pain. 10, 11 In this study we tested the ability of locally applied repetitive magnetic stimulation (rMS) to relieve patients with musculoskeletal pain.
Subjects and Methods
Patients suffering pain for more than 2 weeks as a consequence of localized injury to the musculoskeletal system were considered for inclusion in this study. Patients with infectious or rheumatic diseases and severe systemic disorders were excluded. Study protocol included personal history, painful process duration, previous treatment, physical examination, specific pain assessment and basic laboratory tests.
Thirty patients, 19 women and 11 men with a mean age of 54.2 ± 13.2 (s.d.) years, were recruited for the study, which had been approved by the local investigational review board. All patients gave their written informed consent. The painful processes had a mean duration of 17.8 ± 18.3 months. Specific diagnoses were painful shoulder with abnormal supraspinatus tendon on magnetic resonance imaging (n = 6), lateral epicondylitis of the elbow (n = 6), electrophysiologically diagnosed ulnar nerve compression syndrome (n = 1) and carpal tunnel syndrome (n = 2), traumatic semilunar bone injury (n = 1), traumatic amputation neuroma of median nerve (n = 1), persistent muscle spasm of upper (n = 3) and lower back (n = 3), inner hamstring tendinitis (n = 2), patellofemoral arthrosis (n = 1), osteochondral lesion of the talus (n = 2), and posterior tibial tendinitis (n = 2).
Study design: Analgesic drugs were discontinued at least 1 day before study entry in the case of patients following treatment (seven cases). Patients were randomized to receive real rMS (n = 15) or sham stimulation (n = 15). However, patients were told that The effect of repetitive magnetic stimulation on localized musculoskeletal pain there were two different stimulation procedures and that one aim of the study was to evaluate which procedure was more efficient against pain. Consequently, none of the patients were aware of receiving placebo stimulation. Pain was assessed both 20 min before and after each session by an examiner also blind to the patient's group assignment. As the investigator applying the stimulation could not be blinded, we attempted to minimize his influence by limiting the conversations to the same topics during both study group sessions (i.e: weather conditions, comments on the hospital, patient's job and neighbourhood).
In the secondary (cross-over) study phase, patients first included in the sham group received real rMS, 1 h later the same day. These patients were informed that a second type of treatment would be applied to adjust technical variables, but were unaware of the placebo nature of the previously received session until the study was completed.
Patients showing a pain score reduction of < 50% received a second rMS session 1 day later (13 cases) to roughly estimate the additive effects of rMS treatment. Thereafter, all patients were followed up 1 week later to assess the duration of pain control and possible adverse effects.
Pain assessment: Patients were required to evaluate their current localized pain. They were instructed to focus on pain at rest, pain generated by local pressure and pain caused by selective movements. In the latter case, the examiner required patients to perform specific movements that usually produced pain in each particular case. Patients separately evaluated these three pain qualities and provided a single overall rating using the 101-point Numerical Rating Scale, 12 in which the severity of pain is established between 0 (no pain) and 100 (unbearable pain).
Treatment intervention: Treatment was administered using a Magstim Super Rapid stimulator (Magstim Company Ltd, Whitland, Wales, UK). Two different coils were alternatively employed in each session, as heating prevents prolonged coil use. These coils were a focal 70 mm 8-shaped and a 90 mm circular coil. Both have different stimulation qualities, 13 but they may complement each other to cover a painful area. The stimulation session always began with the 8-shaped coil that was used until coil heating reached 40°C and then replaced by the circular coil. Magnetic stimulation was focused on the painful region as is illustrated in Fig. 1 . The specific coil location was adjusted to the area of tenderness identified by palpation.
Eight-thousand pulsed magnetic stimuli were administered throughout each 40 min session in 5 s trains at 20 Hz (100 stimuli/train), separated by 25 s pauses. Stimulation intensity was adjusted in each patient based on the patient's subjective report. It became clear early in the study that all patients experiencing localized pain perceive a characteristic feeling when rMS is applied to the painful region. Such a sensation usually reminds the patient of his or her pain, is sharp in character, well localized and particularly dependent on coil position and stimulation intensity. To define the stimulation intensity, we started stimulating at 20% of maximal output power and increased the intensity by 5% steps until the patient perceived significant local sensation without excessive discomfort. Such an intensity threshold differs from patient to patient and depends mainly on the depth of the injured region. Mean ± s.d. stimulation intensity delivered in this study was 35.2 ± 6.4% when the 8-shaped coil was used and 30.1 ± 4.7% for the circular coil.
Sham stimulation:
The same tools were used for the purposes of sham stimulation, but the coil position was modified (Fig. 1B) to direct magnetic stimulation outside the region of interest. Slight pressure was exerted at this position to produce slight pain sensation and mimic the sensation reported by the patients J. Pujol et al. during real rMS. Once again, the exact coil position was adjusted by tender area palpation. As there is a certain controversy as to rMS stimulation ability for the adopted position, 14 we used lower repetition rate (4 Hz) at lower intensity (15% of maximal power) to deliver less energy.
Statistical analysis:
The nonparametric two-tailed Mann-Whitney U test and Wilcoxon's matched-pairs rank test were used due to the significant standard deviation differences in pain scores between both study groups. The paired Student's t-test was used in the follow-up analysis.
Results
Mean pain intensity at baseline for all patients was 53.3 ± 18.8 (s.d.) points on the 101-point Numerical Rating Scale. rMS and sham study groups showed comparable age, gender distribution, complaint duration and baseline pain score (Table 1) .
Sham-controlled single session effect:
After a single session, the group of patients who received real rMS showed a reduction of 28.8 ± 18.5 points (59 ± 28%) in the 101-point rating, whereas patients treated with sham stimulation improved by only 7.6 ± 9.4 points (14 ± 16%; significant differences; z = -3.26, p = 0.001). Figure 2 illustrates this main finding.
Patients initially treated with sham stimulation improved a mean of 29.8 ± 17.6 points after receiving real rMS in the cross-over study phase. The differences were significant (z = -3.41, p = 0.0007; matchedpairs Wilcoxon test).
rMS produced a variable patient to patient effect, as reflected by the notably large standard deviation in the percent pain score reduction following real rMS (56 ± 26%) in the whole series. Two patients obtained no benefit (amputation neuroma and patellofemoral arthrosis), whereas four patients showed a pain score reduction > 85% after a single session (two suffering from upper back muscle spasm, one from rotator cuff injury and one from osteochondral lesion of the talus).
One week follow-up: All 30 patients, after receiving single (n = 17) or double (n = 13) rMS session, were followed up for 1 week to estimate effect duration. Figure 3 shows the follow-up assessment for the whole series. We observed a significant remaining effect at the end of this period, as patients scored 22.0 ± 20.0 points in the 101-point numerical rating. This figure was largely below the initial value of 53.3 ± 18.8 points (t = 7.86, p < 0.001, paired t-test). Safety and tolerance: All patients tolerated rMS well. None of the patients reported excessive discomfort during stimulation or experienced worse pain immediately after the sessions. No patient showed a rebound effect in the entire follow-up period.
Discussion
The reduction of pain that followed a single rMS session significantly exceeded the sham effect in this study, in which stimulation was applied on the injured region in patients with localized musculoskeletal pain. Powerful magnetic coil stimulation produces efficient muscle and peripheral nerve responses, which are comparable in magnitude to the responses obtained with conventional electrical stimulation. 8, 15 The advantage of rMS over electrical stimulation lies in its painlessness, which allows stronger stimulation intensity. Our results suggest that rMS, like electrical nerve stimulation, 10, 11 may interfere with the abnormal neural transmission occurring in chronic pain states. Nevertheless, the observed rMS effect cannot be a simple electrical blockage, as it persists for days after the rMS session has been completed.
Several controlled studies have suggested that electromagnetic stimulation itself may reduce pain. Indeed, either static magnetic fields, 16 low intensity pulsed electromagnetic stimuli, 17, 18 or high intensity magnetic stimulation at low rate 19 have proved to be superior to placebo in double-blind trials. However, the mechanisms of action of these interventions remain to be established as the interaction between magnetic fields and biological tissues is largely unknown. 16 In our study, the striking results may in fact raise more questions than answers in the field of pain research. We do not know the extent to which effective stimulation is electrical, magnetic, or both. Nor do we know where the crucial neural changes (receptors, axons, neurotransmission) occur after an rMS session. Moreover, the relevance of each stimulation parameter has not been established at present. Is stimulation on the tender region critical? Is stimulation frequency or stimulation intensity relevant? All these issues need to be carefully investigated through new studies. Nevertheless, rapid progress in understanding the pathophysiology of pain promises specific answers in the near future. 20 Our findings need to be considered preliminary and several important issues deserve discussion. We were careful to conduct sham stimulation in a similar way to real rMS, nevertheless, patient local sensation in the sham condition was slightly different and coil discharge noise was softer and slower. We did not expect relevant loss of placebo effect from these differences, but they should be controlled when possible in future studies. More critical may be the influence of the investigator applying the stimulation. To minimize this bias as much as possible, we made sure to reproduce similar therapist intervention in both study groups, but coil holding devices might be desirable to resolve this variable in future research.
